Coveo's Passage Retrieval API delivers precise, trustworthy text to large language models and AI applications, including Salesforce Agentforce, Microsoft Copilot, Amazon Bedrock Agents, and SAP Joule.

Neurocrine Biosciences Inc (NBIX) reports robust sales growth and strategic investments amid competitive pressures and payer challenges.

CNW/ - Coveo (TSX: CVO), the market leader in AI-Relevance — delivering AI-search, generative, and business-aware relevance ...

Merck's combination of a wide lineup of high-margin drugs and a pipeline of new drugs should ensure strong returns on invested capital over the long term. Further, following the divestment of the ...

Neurocrine Biosciences (($NBIX)) has held its Q4 earnings call. Read on for the main highlights of the call. Neurocrine Biosciences’ earnings call ...

CEO Ivan Tornos highlighted that Zimmer Biomet achieved nearly 5% constant currency sales growth in Q4 2024, marking the 12th consecutive quarter of mid-single-digit or better growth. The performance ...

Dayforce is committing to ~15% revenue growth and 100-150bps of margin expansion over the next few years. Read why DAY stock ...

The main focus in Teva’s innovative portfolio continues to be neuroscience and immunology, with clinical trials for three key ...

Humantic AI, a pioneer of the Buyer Intelligence category for B2B sales, today announced that it has been named a Cool Vendor ...

HighlightsTotal revenue of $1.66 billion, up 17% year over yearProduct revenue of $574 million, up 18% year over yearBillings ...

Q4 2024 Earnings Call Transcript February 4, 2025 AudioCodes Ltd. beats earnings expectations. Reported EPS is $0.37, ...

Cloud software seller Salesforce said on Monday that it plans to invest $500 million in Saudi Arabia related to artificial ...